As of 2024-09-09, the Fair Value of Akebia Therapeutics Inc (AKBA) is -0.96 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.35 USD, the upside of Akebia Therapeutics Inc is -171.25%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -279.70 | -384.80 | -282.00 | -94.20 | -51.92 | -218.53 |
| YoY growth | -94.78% | -37.58% | 26.72% | 66.60% | 44.88% | 1.17% |
| Market Cap (mil) | 283.89 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | 1.17% |
| TTM earnings | -40.45 |